Hematological Malignancies | Norton Healthcare

Indication: Hematological Malignancies

Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology


Sub-indication: Hodgkin lymphoma

Line of Therapy: second line


Principal Investigator: Don Stevens, M.D.
Norton Cancer Institute

Sponsor: Bristol-Myers Squibb

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.